In this executive summary, experts will present the in vitro dissolution and an in vivo bioequivalence study comparing the performance of the identical formulation of three different drugs in Capsugel® Vcaps® Plus capsules to hard gelatin capsules. In addition, the circumstances under which the same API and formulation contained in HGC and Capsugel® Vcaps® Plus can be expected to provide equivalent performance will be discussed.
Get access to the latest news, additional whitepapers, webinars and Knowledge Center content. Already have an account? Log In
Please fill in the form below to log in to your account. Don’t have an account? Create A Free Account Today!